Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser
11/09/2026 12:21
BRIEF-Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser Sept 11 (Reuters) - Bausch + Lomb Corp BLCO.TO:
BAUSCH + LOMB ANNOUNCES EUROPEAN CE MARK APPROVAL OF SEELYRA™ FEMTOSECOND LASER
BAUSCH + LOMB - SEELYRA TO BE AVAILABLE IN EUROPE ON BASIS IN COMING MONTHS, WIDER IN 2027
Source text: ID:nBw3Qtqa
Further company coverage: BLCO.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch + Lomb
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: US FDA sent warning letter to Bausch & Lomb on September 4
Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser